New Jersey is ranked in the top ten nationally for cancer incidence. ScreenNJ is a collaborative project of organizations across the state committed to reducing cancer incidence and mortality through an effective cancer prevention and screening program. Colorectal cancer and lung cancer are among the most prevalent in the state. In order to help improve the health of New Jersey’s residents, the initial focus of ScreenNJ is on colorectal cancer and lung cancer. These cancers have better outcomes if detected early through proven screening methods such as colonoscopy for colorectal cancer and low dose computerized tomography (CT) scans for lung cancer.

Under the leadership of Rutgers Cancer Institute of New Jersey and working in partnership with the New Jersey Department of Health, primary care providers, and a number of organizations throughout the State, the goal of ScreenNJ is to increase screening for colorectal and lung cancer, to reduce cancer mortality rates, and to educate New Jersey residents about the importance of cancer screening, early detection, and prevention. ScreenNJ was launched in 2017 and is funded in part by the State.